Wuhan Wansheng Biotechnology: difference between revisions
Diff·revision 28 → 29·07:25, 30 Nov 2024
Difference between revision 28 and revision 29 of Wuhan Wansheng Biotechnology. 5 lines changed; the page grew by 868 bytes.
| Revision 28 — 09:04, 22 Nov 2024 LotTraceLuka (talk) attribute range as a review estimate per talk 6,411 bytes +482 | Revision 29 — 07:25, 30 Nov 2024 NPOV_Nadia (talk) ce 7,279 bytes +868 | ||
|---|---|---|---|
| 49 | The catalogue is broad and the documentation inconsistent across it — an unusual combination, and one that makes generalisation from any single order unsafe.{{r|reports}} | 49 | The catalogue is broad and the documentation inconsistent across it — an unusual combination, and one that makes generalisation from any single order unsafe.{{r|reports}} |
| 50 | 50 | ||
| + | 51 | == Independent testing record == | |
| + | 52 | The report set associated with this organisation is the largest on the wiki, with several hundred third-party reports across a wide range of analytes.{{r|reports}} Reported [[Area percent purity|area percent]] figures span a wider range than for most entities covered here, with the majority in the high nineties and a visible tail below. | |
| + | 53 | ||
| + | 54 | '''What that tail means is genuinely contested.''' A large report set will contain more low results than a small one simply by being larger, and a set assembled from purchaser submissions is self-selected in ways that may over- or under-represent poor outcomes: a purchaser who suspects a problem is more likely to test, and a purchaser with a good result is more likely to publish. Neither bias has been quantified, and the article does not claim to know the net direction.{{r|reports,tally}} | |
| + | 55 | ||
| 51 | == References == | 56 | == References == |
| 52 | {{reflist}} | 57 | {{reflist}} |